Χώρα: Γερμανία
Γλώσσα: Αγγλικά
Πηγή: HMA (Heads of Medicines Agencies)
carprofen 20 mg
Norbrook Laboratories Limited
QM01AE91
Tablet
carprofen
Dogs
2011-09-03
Revised: April 2011 AN: 00689/2010 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Carprogesic 20mg Tablets for Dogs (UK, France) Paracarp 20mg Tablets for Dogs (Germany) Norocarp 20mg Tablets for Dogs (Belgium, Luxembourg) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active Ingredient: Carprofen 20 mg Excipients: For a full list of excipients see Section 6.1 3. PHARMACEUTICAL FORM Tablet A white/off white circular tablet of 8 mm diameter, 20 embossed on one side and a single breakline on the other side. 4. CLINICAL PARTICULARS 4.1 _TARGET SPECIES:_ Dogs 4.2 _INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES:_ In the dog: Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post-operative pain. 4.3 _CONTRAINDICATIONS:_ Do not use in cats. Do not use in puppies less than 4 months of age. Do not use in case of hypersensitivity to active substance or to any of the excipients. Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia. Refer to section 4.7 4.4 _SPECIAL WARNINGS FOR EACH TARGET SPECIES:_ Refer to Sections 4.3 and 4.5. Revised: April 2011 AN: 00689/2010 Page 2 of 5 4.5 _SPECIAL PRECAUTIONS FOR USE:_ SPECIAL PRECAUTIONS Διαβάστε το πλήρες έγγραφο